Form 8-K - Current report:
SEC Accession No. 0001140361-22-021148
Filing Date
2022-05-31
Accepted
2022-05-31 07:30:29
Documents
16
Period of Report
2022-05-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10038309_8k.htm   iXBRL 8-K 61556
2 EXHIBIT 10.1 brhc10038309_ex10-1.htm EX-10.1 131768
3 EXHIBIT 10.2 brhc10038309_ex10-2.htm EX-10.2 49221
4 EXHIBIT 99.1 brhc10038309_ex99-1.htm EX-99.1 14946
8 image1.jpg GRAPHIC 6101
  Complete submission text file 0001140361-22-021148.txt   465587

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA btx-20220509.xsd EX-101.SCH 3929
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20220509_lab.xml EX-101.LAB 22544
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20220509_pre.xml EX-101.PRE 16047
10 EXTRACTED XBRL INSTANCE DOCUMENT brhc10038309_8k_htm.xml XML 4245
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 22980474
SIC: 2834 Pharmaceutical Preparations